How do you take that first step and balance clinical duties with non-clinical interests? What specific advances in biotech could have the potential to revolutionize clinical treatment in the near future? What factors are you optimizing for in your career plan? Join this episode as Dr. Sam Kessel answers these questions and more and shares his story!
Sam completed his intern year in internal medicine. He was an associate for multiple angel networks, performing part-time due diligence on medical startups during medical training. He then went on to become a Consultant at LEK Consulting. He is now an associate at Locust Walk, where he works with various biotech companies using cutting-edge technologies to help them find partners and funding. He hosts the Nucleate Signal podcast and interviews folks who are the next generation of leaders in biotech.
He got his Bachelor's from Tufts University, MD from the University of Virginia School of Medicine, and MBA from the University of Virginia Darden School of Business.
We volunteer our time and money to make this content freely available – if you enjoy our content and find it helpful, you can support us by buying us a coffee here!
What are the biggest barriers to digital therapeutics, and how will the field evolve down the line? How can we make MDs excited about...
What are some of the inflection points that are needed to unlock the commercial side of the market of digital therapeutics? How can MDs...
Join us as Lincoln Nadauld, CEO of Culmination Bio, delves into the crucial role of genomics-powered precision medicine in Oncology research. Discover the main...